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Abstract
Background: To facilitate deciphering underlying transcriptional regulatory circuits in mouse embryonic stem (ES)
cells, recent ChIP-seq data provided genome-wide binding locations of several key transcription factors (TFs);
meanwhile, existing efforts profiled gene expression in ES cells and in their early differentiated state. It has been
shown that the gene expression profiles are correlated with the binding of these TFs. However, it remains unclear
whether other TFs, referred to as cofactors, participate the gene regulation by collaborating with the ChIP-seq TFs.
Results: Based on our analyses of the ES gene expression profiles and binding sites of potential cofactors in
vicinity of the ChIP-seq TF binding locations, we identified a list of co-binding features that show significantly
different characteristics between different gene expression patterns (activated or repressed gene expression in ES
cells) at a false discovery rate of 10%. Gene classification with a subset of the identified features achieved up to
20% improvement over classification only based on the ChIP-seq TFs. More than 1/3 of reasoned regulatory roles
of cofactor candidates involved in these features are supported by existing literatures. Finally, the predicted target
genes of the majority candidates present expected expression change in another independent data set, which
serves as a supplementary validation of these candidates.
Conclusions: Our results revealed a list of combinatorial genomic features that are significantly associated with
gene expression in ES cells, suggesting potential cofactors of the ChIP-seq TFs for gene regulation.
Background
A set of core transcription factors (TFs) have been
reported to regulate the self-renewal and pluripotency of
mouse embryonic stem (ES) cells. Oct4 has long been
regarded as one of the master regulators in ES cells.
Oct4-deficient embryos fail to produce pluripotent inner
cell mass [1]. Furthermore, while repression of Oct4
allows trophectoderm development, a less-than-twofold
increase in Oct4 expression drives differentiation into
primitive endoderm and mesoderm [2]. Together with
Oct4, Sox2 explains the first three lineages present in
preimplantation development; both factors are essential
to epiblast formation, and in their absence trophec-
toderm is formed [3]. Nanog, another master factor, can
bypass leukemia inhibitory factor (LIF)/STAT3 to main-
tain ES cell self-renewal [4,5], and Nanog-deficient ES
cells lose pluripotency and differentiate into extraem-
bryonic endoderm lineage [5].
In addition to the three master TFs, implications of the
regulatory roles of a few other TFs in mouse ES cells have
been obtained via experimental efforts. LIF signal pathway
can sustain self-renewal of the cells by activating STAT3
[6]; BMPs collaborate with LIF for the maintenance of
self-renewal via triggering the phosphorylation of Smad1
to induce Id genes [7]. Myc and Klf4 are two of the four
factors that can reprogram somatic cells to pluripotent
cells [8]. Esrrb is required for efficient self-renewal of ES
cells in vitro; it is required to block differentiation into
mesoderm, ectoderm and neural crest cells [9]. Depletion
of Zfx impairs self-renewal of ES cells while over-expres-
sion of the factor can facilitate the self-renewal [10].
To reconstruct the regulatory network in mouse ES
cells, genome-wide binding data of these important TFs
have been generated by ChIP-seq/chip experiments
[11-13]. In particular, Chen et al. [11] made available
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ChIP-seq data of the following 12 TFs in mouse ES cells:
Oct4, Sox2, Nanog, STAT3, Smad1, Myc, Klf4, Zfx, Esrrb,
Mycn, Tcfcp2l1, and E2f1. We refer to them as main fac-
tors. The authors showed that the binding of these factors
is correlated with retinoic-acid-induced gene expression
profiles [9]. Furthermore, Ouyang et al. [14] built statistical
models upon the ChIP-seq data, which can explain sub-
stantial variation in gene expression in mouse ES cells
[15,16]. However, the following problem remains to be
investigated: Whether other TFs that bind together (or co-
bind) with main factors, referred to as cofactors, can
further explain expression patterns? In this study, with the
ChIP-seq data in [11] and the expression data in [16], we
attempt to answer this question by exploring association
between the gene expression and binding sites of potential
cofactors on genomic islands co-occupied by groups of
main factors. We intend to evaluate whether the associa-
tion is different between different expression patterns, and
according to the evaluation, we recommend a small set of
cofactors for future follow-up experimental validation. To
this end, we perform the following analyses (Figure 1) and
report their results in this article.
1. Clustering analysis of the ChIP-seq data and the
gene expression profiles revealed that genes sharing
similar binding patterns of the main factors may still
have distinctive expression patterns, leading to our
hypothesis of existence of cofactors. The k-means
clustering was employed in this step.
2. We then constructed features characterizing co-
binding effects of main factors and a cofactor candi-
date on their potential target genes. In order to inte-
grate genomic information of cofactor candidates with
the main factor binding data, we scanned genome
regions defined by the ChIP-seq coordinates with a set
of known TF motifs to identify co-localization of bind-
ing sites of main factors and a cofactor candidate in
the genome; next, we computed a feature score for a
gene and a feature–a combination of (co-localized)
main factors and a cofactor candidate–such a score
intends to quantify association strength between a
gene and a co-binding combination, giving a numerical
summary of the genomic sequence information and
the ChIP-seq data for the gene.
3. Through hypothesis tests, we identified features
which have significantly different distributions
between ES-up genes and ES-down genes represent-
ing genes up- and down-regulated in ES cells, respec-
tively (see Results for their definitions). By checking
expression profiles of a cofactor candidate involved in
by scanning cofactor binding sites and 
Cluster genes based on ChIP−seq data
with k−means clustering Hypothesis of cofactor existence 
Construct combinatorial binding features
associating co−binding TF combinations
with genes
Identify significant features by
two−sample comparisons  Reason cofactor regulatory roles
Classify genes by naive Bayes classifiers  Report potential cofactors
Predict target genes  Support reported cofactors
Figure 1 The diagram of the analysis procedure. The main steps are listed on the left, and their corresponding results/purposes are indicated
on the right.
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a feature, we reasoned its regulatory role based on
test results. Two-sample proportion test and the Wil-
coxon rank-sum test were used, with the false discov-
ery rate (FDR) controlled by the Benjamini-Hochberg
procedure [17].
4. Regarding ES-up and ES-down genes as two classes
of genes and significant features identified in the last
step as predictors, we adopted gene classification with
naïve Bayes classifiers to further choose a small subset
of features, which suggest cofactor candidates through
involved TF combinations.
5. Finally, we predicted target genes of TFs involved in
selected features by perturbing learned classifiers and
examining change in classification. We reported con-
sistent evidence supporting our prediction from
another independent data set. The purpose of this
practice is to provide supplementary validation of
cofactor candidates revealed by selected features via
the target prediction.
For brevity, we refer to cofactor candidates as
cofactors.
Results
Hypothesis of existence of cofactors
We first define gene sets of our interest and introduce
some existing findings about the main factors based on
the ChIP-seq data, and then present their interplay results
to motivate our hypothesis of existence of cofactors and
further analyses.
ES-up and ES-down genes
Zhou et al. [16] produced gene expression profiles at ES-
cell stage and early differentiated stage, including 3 profiles
of undifferentiated ES cells (with high Oct4 expression),
5 profiles of 2-, 4-, 8-day embryoid bodies with high Oct4
expression, and 8 profiles of 2-, 4-, 8-, 15-day embryoid
bodies with low Oct4 expression. Regarding high Oct4
expression as a marker for ES cells, we refer to the 8 pro-
files with high Oct4 expression as samples at ES stage and
the remaining profiles as samples at DF (differentiation)
stage. Two gene sets have been identified: The genes
whose expression is higher at ES stage than at DF stage
with a fold change > 2 and P-value< 0.05 in a two-sample
comparison, and the genes that have significantly lower
expression at ES stage comparing with expression at DF
stage under the same cutoffs. We refer to the first set of
genes as ES-up genes and the second set of genes as ES-
down genes. We call these two sets of genes collectively ES
genes.
The Myc group and the Oct4 group of the main factors
In the ChIP-seq data [11], a pair of start and end coordi-
nates specifies a peak location or a binding site of a TF in
coarse resolutions, and the number of reads (after nor-
malization) associated with a peak indicates the intensity
of binding signals on the site. The authors showed that
Oct4, Sox2, Nanog, Smad1, and STAT3 have different
binding patterns from Myc and Mycn. Ouyang et al. [14]
reported a similar phenomenon. Specifically, they first
defined an association score to measure association
strength between a gene and a main factor (see Meth-
ods). Intuitively, the closer the binding sites (peaks) of a
main factor to the transcription start site (TSS) of the
gene, and the stronger the ChIP-seq signal intensities
(the number of reads) on the sites, the higher the associa-
tion score between the gene and the main factor.
Through principal components analysis of the association
scores of all the main factors, they identified two groups
of TFs: The Myc group consists of E2f1, Zfx, Mycn, and
Myc; the Oct4 group has Oct4, Sox2, Nanog, Smad1,
STAT3, Tcfcp2l1, and Esrrb. While the Myc group is
mainly associated with up-regulated genes in ES cells, the
Oct4 group may either activate or repress genes at ES
stage according to their regression analysis of the associa-
tion scores and expression data.
Gene clusters based on association scores
Having learned the differences between these two TF
groups, we intended to examine whether genes can be rea-
sonably partitioned according to the association scores.
This examination was to check whether a similar binding
pattern shared by a set of genes would lead to similar
expression of the genes. We applied the k-means cluster-
ing to genes based on their association scores with the 12
main factors (reported in [14]), and chose k = 5 as we may
expect four clusters of genes associated with the binding
of none/either/both of the two groups, leaving an addi-
tional cluster accommodating any unexpected binding pat-
tern. Figure 2 shows the mean association scores for the
five clusters and the grand mean association scores over
all the genes (note that the grand means of different TFs
are all around 1.25 because of quantile normalization in
[14]). We observed distinguished binding patterns among
these five clusters. By comparing the mean association
scores with the grand means, we see that cluster 1 includes
genes highly associated with all the TFs; in contrast, clus-
ter 5 consists of genes having weak association with all of
them. Cluster 2 has genes more intensively associated with
the Oct4 group than the Myc group; in cluster 3, conver-
sely, the Myc group shows stronger association than the
Oct4 group; similar to cluster 2, cluster 4 contains genes
for which the Oct4 group owns higher association scores
than the Myc group, although the association is relatively
moderate comparing with the association for cluster 2. For
future reference, we name the five clusters according to
the observed binding patterns: The uniformly-high cluster
for cluster 1, the uniformly-low cluster for cluster 5, the
Oct4 cluster for cluster 2, the Myc cluster for cluster 3, and
the Oct4-moderate cluster for cluster 4. We excluded the
uniformly-low cluster from further investigation because
we were interested in finding cofactors working with the
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main factors in ES cells and all the main factors are weakly
associated with the genes in that cluster.
Figure 3 shows the association scores of ES genes in
the remaining four clusters and their corresponding
expression profiles (see Additional file 1 for visualization
of two components of association scores: ChIP-seq
intensities and distances to TSS). Although the genes in
a cluster share a similar binding pattern, a substantial
number of these genes are either up- or down-regulated
at ES stage. For example, the Myc cluster has around
the same number of ES-up genes as ES-down genes. We
hypothesize that cofactor binding may help account for
the two distinct expression patterns in the same binding
cluster. For the Oct4 cluster and the Oct4-moderate
cluster, we hope to find cofactors collaborating with the
members of the Oct4 group–note that the Oct4 group
has stronger association than the Myc group in these
two clusters–and thus, the TFs in the Oct4 group are
called the main factors of interest for these two clusters;
analogously, for the Myc cluster, the members of the
Myc group are the main factors of interest; for the uni-
formly-high cluster, all the 12 TFs are the main factors
of interest.
Meanwhile, we focus on ES genes in these four clus-
ters (see Additional file 2). Our goal is to search for
cofactors whose co-binding (with corresponding main
factors of interest) to ES-up genes and to ES-down
genes in a cluster are significantly different from each
other, and can optimally classify the genes within the
cluster.
Figure 2 Mean association scores of gene clusters. Each data point in the figure indicates the mean of the association scores of a cluster of
genes for a TF. The vertical broken line separates the Myc group and the Oct4 group. “Clusters 1-5” indicates the grand mean scores of all the
genes for a TF.
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Features and feature scores
A feature is defined as association between genes and a
combination of w main factors of interest and one cofac-
tor. Such a combination is referred to as a TF combina-
tion. We consider three types of features corresponding
to w = 2, 1 and 0: A pair of main factors and a cofactor, a
single main factor and a cofactor, and a cofactor alone.
Whereas a cofactor prefers to co-bind to DNA sequences
with two or one specific main factor for the first two
types of features, respectively, the last type does not indi-
cate such preferences. Depending on main factors of
interest in a cluster, features involving TF combinations
constructed in different clusters are different. For exam-
ple, for the Myc cluster, a TF combination consists of
Figure 3 Association scores and expression profiles with genes aligned between (a) and (b). (a) Association scores of the ES genes that
are in the uniformly-high cluster, the Oct4 cluster, the Myc cluster, and the Oct4-moderate cluster, with cyan-colored horizontal lines indicating
boundaries between the clusters. (b) Gene expression profiles with the first 8 conditions corresponding to ES stage and the rest corresponding
to DF stage, annotated by the number of ES-up (indicated by “up”) genes and ES-down ("down”) genes in each cluster. Note that genes within a
cluster are sorted according to their expression fold change. Association scores and gene expression profiles are the same as the ones generated
in their original papers. Specifically, the association scores are log-transformed and quantile-normalized [14]; the gene expression profiles in [16]
are normalized by the invariant set method implemented by dChip [37]. For display purpose, both the association scores and the gene
expression profiles are rescaled to the range between -2 and 2.
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one or two of the main factors of the Myc group (E2f1,
Mycn, Zfx, and Myc) and one cofactor. Thus, different
clusters have different numbers of features. Given 202
pre-selected potential cofactors (see Methods for selec-
tion criteria and Additional file 3 for pre-selected cofac-






)× 202) features with w = 2
and 2424 features with w = 1 for the uniformly-high clus-
ter. For the Oct4 and Oct4-moderate clusters, there are
4242 and 1414 features corresponding to w = 2 and w =
1, respectively. For the Myc cluster, there are 1212 fea-
tures with w = 2 and 808 features with w = 1. Finally,
there are 202 features involving only cofactors (w = 0) for
all the clusters.
To locate places where a co-binding of a TF combina-
tion may happen, we identified genomic regions that
contain at least two binding sites of main factors of
interest in the ChIP-seq data. Such a genomic region is
called a neighborhood. Please see Methods for neighbor-
hood construction and Additional files 4, 5, 6 for neigh-
borhood summary statistics such as their lengths and
distances to TSS’s. As mentioned above, for different
clusters, features are different depending on different
main factors of interest, and thus different subsets of
the ChIP-seq data were used for neighborhood con-
struction. For example, the ChIP-seq data of E2f1,
Mycn, Zfx, and Myc were used for the Myc cluster. We
then scanned the neighborhoods with the 202 pre-
selected TF motifs from TRANSFAC 12.1 [18] and de
novo motif discovery to detect possible binding sites of
these potential cofactors (see Methods).
Next, a neighborhood is associated with a gene if its
center is within d bps of the gene’s TSS (See Methods for
how to specify d). Given a gene and its associated neigh-
borhoods containing binding sites of main factors and a
cofactor involved in a TF combination, we computed a
feature score to quantify the association strength between
the TF combination and the gene (see Methods). Intui-
tively, a greater feature score is due to a shorter distance
from the location of the TF combination to the TSS and/
or a stronger binding strength of the combination.
If a TF combination cannot be associated with a gene
because it does not occur in any associated neighbor-
hood of the gene, we say that the feature score between
this combination and the gene does not exist (see Addi-
tional files 7, 8, 9, 10, 11, 12 for all feature scores).
Feature significance
For each feature, we employed two-sample comparisons
to test whether the feature score distribution of ES-up
genes is significantly different from the distribution of
ES-down genes. Specifically, the Wilcoxon rank-sum test
was utilized to test whether the feature scores in one
gene set are significantly greater than the feature scores
in the other (due to non-normality of feature score
distributions, the nonparametric test was employed);
two-sample proportion test was used to test whether the
proportion of the genes associated with a TF combina-
tion (involved in the feature) in one gene set is signifi-
cantly greater than that in the other.
For each type of features, many features lead to a multi-
ple testing problem for each kind of test. (Note that a fea-
ture type is defined by w = 2, 1, 0, the number of main
factors in a TF combination as presented in the last sec-
tion. For example, features involving two main factors are
one type of features.) We collected significant features
under an FDR cutoff of 10%. We define an ES-up feature
as a feature that shows a higher proportion in ES-up genes
than that in ES-down genes or has significantly higher
scores in ES-up genes than ES-down genes. An ES-down
feature is defined in an analogous way. Table 1 sum-
marizes the number of significant features in each cluster
(see Additional file 13 for significant features). For the
Oct4 cluster, there are only a few significant features with
w = 0 but many more significant features with w = 1 or 2.
For the Myc cluster and the Oct4-moderate cluster, there
are also more significant features involving a TF combina-
tion than features involving only a cofactor. The result
demonstrates that we would have ignored important fea-
tures if we only considered cofactors alone, and that the
constructed features are effective to capture a cofactor’s
preference for co-binding with main factors for potential
gene regulation.
Interestingly, almost all significant ES-up features were
discovered by the rank-sum test. This fact may suggest
activation of genes at ES stage is more likely to happen
when a TF combination is located closer to TSS’s, and/or
it has a stronger binding strength. In contrast, all signifi-
cant ES-down features were identified by two-sample
proportion test. This phenomenon indicates that the
occurrence of a particular TF combination may be suffi-
cient to increase the chance of down-regulation at ES
stage–neither its location nor its strength makes differ-
ences. Since utilizing features in continuous and binary
fashions informs us different meanings, both are useful
and should be considered together.
We can reason regulatory roles of a cofactor involved
in a significant feature by checking its fold change in
Table 1 Numbers of ES-up (U) and ES-down (D) features
(FDR < 10%) in different clusters
w = 2 w = 1 w = 0
U D U D U D
uniformly-high cluster 2 0 4 3 1 14
Oct4 cluster 7 186 22 10 8 2
Myc cluster 3 76 7 141 0 63
Oct4-moderate cluster 464 0 366 0 102 0
Note: w denotes the number of main factors, indicating feature types.
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the expression profiles and checking whether the feature
is an ES-up or ES-down feature. Fold change in the
expression profiles is said to be positive if the ratio of
the mean expression at ES stage over the mean expres-
sion at DF stage > 2, and negative if the ratio < 0.5. By
its definition, an ES-up feature is significantly associated
with genes that are up-regulated at ES-stage (and down-
regulated at DF stage). Therefore, if a cofactor involved
in an ES-up feature shows positive fold change, it may
play an activator role in ES cells. On the other hand, if
the cofactor is active at DF stage, suggested by its nega-
tive fold change, it may repress genes at DF stage. For a
cofactor with neither positive fold change nor negative
fold change, it may show uniformly high expression,
defined by average expression index > 500 at both ES
and DF stages, and thus may function at both stages. In
this case, we may not tell its role as an activator at ES
stage from an repressor at DF stage. Following the same
logic, we can reason the roles of a cofactor involved in
an ES-down feature as either a repressor at ES stage
and/or an activator at DF stage. Table 2 summarizes the
above reasoning.
Feature selection
Based on the significant results we obtained, we further
selected a small subset of features with gene classification,
where top features ranked by their significance (according
to the tests described in the previous section) were treated
as predictors in a naïve Bayes (NB) classifier and ES-up
and ES-down genes as two classes (see Methods).
Since ES-up and ES-down features indicate different bio-
logical meanings, we hoped to incorporate information
from both ES-up and ES-down features into predictors.
To reduce potential combinations of three types of ES-up
features (corresponding to w = 2, 1, 0) and three types of
ES-down features as indicated by six columns in Table 1,
we restricted our search strategy to combining only one
type of ES-up features and only one type of ES-down fea-
tures, and thus there are a total of 9 (= 3 × 3) combina-
tions to be examined. Specifically, we used top k1 ES-up
features (of one type) ranked by their P-values and top k2
ES-down features (of one type) as k (= k1 +k2) predictors
in an NB classifier. Figure 4 illustrates the situation where
we examined a combination of one type of ES-up features
(w = 1) and one type of ES-down features (w = 2) based
on ten-fold cross-validation (CV). It shows that the classi-
fication accuracy for enumeration of the two types of
features for the Oct4 cluster, where on average the combi-
nation of top six ES-up features and top two ES-down fea-
tures achieves the highest accuracy (minimum CV error).
The decreasing trend of the accuracy can also be observed
as k1 and k2 increase from six and two, respectively. Simi-
lar enumeration was conducted for the remaining eight
combinations of feature types, and the combination with
the minimum CV error was selected. Please see Methods
for details of the feature enumeration procedure we
employed given two types of features.
Table 3 compares NB classifiers based on only main
factors (and thus using association scores) with those
utilizing both main factors and selected features invol-
ving cofactors. Although little improvement was made
for the uniformly-high cluster and the Oct4-moderate
cluster, incorporating cofactors can reduce 20% and 11%
of CV errors compared to only using main factor effects
for the Oct4 cluster and the Myc cluster, respectively.
Ouyang et al. [14] adopted the CART algorithm on
three principal components of association scores of
main factors for gene classification. As a comparison,
we also classified ES-up and ES-down genes with the
CART algorithm based on the same principal compo-
nents. This approach showed similar performance to the
NB classifiers using only main factors as predictors
(Table 3). Again, it was about 16% worse than the classi-
fiers utilizing cofactor effects for the Oct4 cluster and
the Myc cluster.
There is little improvement by utilizing cofactor infor-
mation in the uniformly-high cluster and the Oct4-mod-
erate cluster. It may be due to more evident imbalance
between ES-up and ES-down genes in each of the two
clusters than the other two clusters–73% ES-up genes in
the uniformly-high cluster and 72% ES-down genes in
the Oct4-moderate cluster. The dominant gene sets may
suggest that gene clustering based on the association
scores (with only main factor information) already parti-
tions the genes well for these two clusters so that the
contribution from features involving cofactors is mar-
ginal for further classification.
Table 4 shows selected features based on the best CV
classification results. We denote a feature by the concatena-
tion of main factor names and the motif name of a cofactor
with dot as separator. A motif name starting with M is
from TRANSFAC, and with N from de novo discovery. For
example, the feature Smad1.STAT3.M00052_NFKB
involves the main factors Smad1 and STAT3 and a cofactor
whose motif name is M00052_NFKB in TRANSFAC.
Figure 5 visualizes how this selected feature helps differenti-
ate the ES-down and ES-up genes in the Oct4 cluster. The
proportion of the ES-down genes associated with this fea-
ture is much higher than that of the ES-up genes. There-
fore, this features is defined as an ES-down feature. On
the other hand, Figure 6 shows that the feature Oct4.
Table 2 Reasoned regulatory roles of a cofactor
Cofactor expression pattern ES-up feature ES-down feature
Positive fold change ES activator (EA) ES repressor (ER)
Negative fold change DF repressor (DR) DF activator (DA)
Uniformly high EA and/or DR ER and/or DA
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Figure 4 Ten-fold CV accuracy with different numbers of ES-up and -down features. Ten-fold CV accuracy with top k1 ES-up features
involving w = 1 main factor and top k2 ES-down features involving w = 2 main factors for the Oct4 cluster, 0 ≤ k1,k2 ≤ 20. The highest CV
accuracy 64% is labeled in the figure, involving top 6 ES-up features and top 2 ES-down features.
Table 3 Ten-fold CV errors and corresponding standard errors
Method uniformly-high cluster Oct4 cluster Myc cluster Oct4-moderate cluster
NB_MF 0.27 (0.02) 0.45 (0.02) 0.42 (0.02) 0.29 (0.02)
CART 0.27 (0.02) 0.43 (0.02) 0.44 (0.02) 0.28 (0.02)
NB 0.26 (0.02) 0.36 (0.02) 0.37 (0.02) 0.29 (0.02)
(NB_MF - NB)/NB_MF 0.04 0.20 0.11 0.00
(CART - NB)/CART 0.04 0.16 0.16 -0.04
Note: NB_MF–classification with NB classifiers based on only main factors; CART–classification with CART based on three principal components of association
scores of main factors as in [14]; NB–classification with NB classifiers utilizing both main factors and cofactors.
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M00801_CREB_Q3 has higher feature scores for the ES-up
gene set than the ES-down gene set, thus making this fea-
ture an ES-up feature.
Although features involving two main factors and one
cofactor are not selected for other clusters, the two ES-
down features for the Oct4 cluster are of this type. In addi-
tion, except the Oct4-moderate cluster, there are features
involving one main factor and one cofactor in all the other
clusters. Not only these features show strong statistical
significance (with FDR < 10%), but also they are useful
from the classification perspective. The evidence from
these aspects suggests that the cofactors involved in these
features are likely to be regulators in ES cells.
Literature support
For more than one third of the features in Table 4,
existing literatures provide supporting evidence of
related biological functions. We list relevant literatures
Table 4 Summary of selected features
Cluster ES U/D Feature Locuslink Cofactor FC Role P-value LS
UH U E2f1.M00233_MEF2_04 17258 Mef2a N DR 8.66E-07
UH U Sox2.M00974_SMAD _Q6_01 17126 Smad2 N DR 1.03E-04
UH U Sox2.M00974_SMAD_ Q6_01 17128 Smad4 H EA/DR 1.03E-04 [38]
UH U Esrrb.M00971_ETS_Q6 13709 Elf1 N DR 1.25E-04
UH U Esrrb.M00971_ETS_Q6 69257 Elf2 N DR 1.25E-04
UH U Esrrb.M00971_ETS_Q6 14390 Gabpa P EA 1.25E-04
Oct4 D Smad1.STAT3.M00052_NFKB 19697 Rela N DA 2.66E-07 [19]
Oct4 D Smad1.STAT3.M00415_AREB6_04 21417 Zeb1 N DA 1.51E-06 [20]
Oct4 U Tcfcp2l1.M00771_ETS_Q4 69257 Elf2 N DR 1.82E-06
Oct4 U Tcfcp2l1.M00771_ETS_Q4 13709 Elf1 N DR 1.82E-06
Oct4 U STAT3.M00251_XBP1_01 22433 Xbp1 N DR 1.37E-05
Oct4 U Nanog.M00462_GATA6_01 14465 Gata6 N DR 2.69E-05 [21]
Oct4 U Nanog.M00134_HNF4_01 15378 Hnf4a N DR 1.05E-04
Oct4 U Esrrb.N00007_SoxOctComp 18999 Sox2 & Oct4 P EA 1.32E-04
Oct4 U Oct4.M00801_CREB_Q3 11911 Atf2 H EA/DR 1.66E-04
Oct4 U Oct4.M00801_CREB_Q3 11908 Atf1 H EA/DR 1.66E-04
Oct4 U Oct4.M00801_CREB_Q3 11910 Atf7 N DR 1.66E-04
Myc D M00233_MEF2_04 17258 Mef2a N DA 3.83E-05
Myc D M00971_ETS_Q6 14390 Gabpa P ER 4.92E-05
Myc D M00971_ETS_Q6 69257 Elf2 N DA 4.92E-05
Myc D M00971_ETS_Q6 13709 Elf1 N DA 4.92E-05
Myc D N00003_Otx2 18424 Otx2 P ER 1.05E-04 [22,23]
Myc D M00034_P53_01 22059 Trp53 P ER 1.61E-04 [24]
Myc D M00421_MEIS1BHOXA9_02 17268 Meis1 N DA 1.95E-04
Myc D M00512_PPARG_01 19016 Pparg N DA 3.64E-04 [25]
Myc D N00009_Klf4 16600 Klf4 N DA 3.97E-04 [26]
Myc D N00009_Klf4 16598 Klf2 P ER 3.97E-04 [26]
Myc D N00009_Klf4 12224 Klf5 H ER/DA 3.97E-04 [26]
Myc D M00764_HNF4_DR1_Q3 15378 Hnf4a N DA 8.46E-04
Myc D M00422_FOXJ2_01 60611 Foxj2 N DA 9.43E-04
Myc D M00724_HNF3ALPHA_Q6 15375 Foxa1 N DA 9.81E-04
Myc D M01011_HNF1_Q6_01 21410 Hnf1b N DA 1.16E-03
Myc U Myc.M00480_LUN1_01 106021 Topors H EA/DR 1.43E-04
Myc U Mycn.M00931_SP1_Q6_01 20683 Sp1 H EA/DR 1.69E-04
Myc U Mycn.N00017_hB_Sall4 99377 Sall4 H EA/DR 1.81E-04 [39]
Oct4-M U M01111_RBPJK_Q4 19664 Rbpj P EA 6.51E-06 [28,29]
Oct4-M U M00450_ZIC3_01 22773 Zic3 P EA 1.74E-05 [30]
Oct4-M U N00001_Sox2 20674 Sox2 P EA 2.45E-04 [3]
Oct4-M U M00225_STAT3_01 20848 Stat3 N DR 2.50E-04 [6]
Note: UH cluster is shorthand for the uniformly-high cluster; Oct4-M cluster is shorthand for the Oct4-moderate cluster. The column “ES U/D” indicates whether a
feature is an ES-up feature (U) or an ES-down feature (D). Locuslinks, cofactor gene names, and fold change (FC) of gene expression (N–negative fold change, P–
positive fold change, H–uniformly high) of cofactors are listed correspondingly. The column “LS” indicates related literature support for a feature.
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for specific features in the last column of the table. Here
we present support for some features in detail. Reported
in the Oct4 cluster, Rela, which binds to M00052_NFKB
sites, was inferred to co-bind with STAT3 and Smad1
for activating genes at DF stage. Lee et al. [19] suggested
that Rela, p300, and STAT3 are in the same DNA-bind-
ing complex in tumors. In addition, they provided
related references showing that Rela and STAT3 stimu-
late a highly overlapping repertoire of prosurvival, prolif-
erative, and proangiogenic genes. The above findings
show that the collaboration exists between STAT3 and
Rela, and our analyses further reveal that there is a need
for these two TFs to work with Smad1 in order to regu-
late genes in ES cells (note that the feature STAT3.
M00052_NFKB only shows marginal significance
with P-value = 0.06). The feature Smad1.STAT3.
M00415_AREB6_04 involves Zeb1, which binds to
M00415_AREB6_04 sites, and Smad1, which is a recep-
tor-regulated Smad (R-Smad) and a key component of
the BMP signaling pathway [7]. Consistently, Postigo
et al. [20] found that Zeb1 synergizes with Smad-
mediated transcriptional activation and regulates BMP
signaling, and that R-Smad and Zeb1 form a complex
that recruits p300 much more efficiently, thus account-
ing for their transcriptional synergy. These results sup-
port Smad1 and M00415_AREB6_04 in the identified
regulatory code, but STAT3 is necessary for them to
receive special attention for ES cell studies–the
Figure 5 For the ES-down feature Smad1.STAT3.M00052_NFKB, association and expression profiles (rescaled for display purpose) with
genes aligned between (a) and (b) in the Oct4 cluster, with the same order in Figure 3. (a) Binary association of the feature with the ES
genes, with value 2 indicating existence of association and value -2 indicating no association. (b) Gene expression profiles with the first 8
conditions corresponding to ES stage and the rest corresponding to DF stage. Similar to Figure 3, the gene expression profiles are normalized
by the invariant set method and rescaled to [-2, 2].
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significance of the feature Smad1.M00415_AREB6_04
(with P-value = 0.02) is not as strong as the reported
three-TF feature (with P-value = 1.51 × 10-6).
According to Gata6’s inferred role from the feature
Nanog.M00462_GATA6_01–a repressor at DF stage, it
may repress genes activated by Nanog at ES stage. This
exemplifies the situation where a main factor and a
cofactor in an identified TF combination may not always
work with each other at the same time. The above rea-
soning is in line with one of the findings in [21], which
demonstrated that antagonism between Nanog and
Gata6 leads to segregation of epiblast and primitive
endoderm within inner cell mass, and that an excess of
Gata6 pushes the cell into the endoderm lineage.
We now discuss some studies on cofactors identified
for the Myc cluster. Consistent with the inferred role of
Otx2 as a repressor at ES stage, the results in [22]
revealed that Otx2 regulates neuronal progenitor
domains by repressing Nkx2.2 in the ventral midbrain.
In another study [23], Puelles et al. suggested that Otx2
represses GABAergic differentiation to control glutama-
tergic progenitors of the thalamus. Another predicted
repressor at ES stage, Trp53, induces differentiation of
mouse ES cells via suppressing Nanog expression [24].
We reasoned that Pparg activates genes at DF stage.
Indeed, it is one of the peroxisome proliferator-activated
receptors (PPARs), a group of three nuclear receptor
isoforms interacting with other factors to increase tran-
scription initiation rate [25].
Although Klf4 is dispensable for maintenance of self-
renewal and pluripotency of ES cells, concurrent deple-
tion of Klf2, Klf4, and Klf5 leads to ES cell differentiation
Figure 6 For the ES-up feature Oct4.M00801_CREB_Q3, feature scores and expression profiles (rescaled for display purpose) with
genes aligned between (a) and (b) in the Oct4 cluster, with the same order in Figure 3. (a) Feature scores for the ES genes. (b) Gene
expression profiles with the first 8 conditions corresponding to ES stage and the rest corresponding to DF stage.
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[26]. Hall et al. [27] showed that Oct4 mainly induces
Klf2 and LIF/STAT3 selectively enhances Klf4 expres-
sion. Our study revealed that the binding sites of these
Klfs are preferentially enriched in the neighborhoods
associated with the ES-down genes in the Myc cluster,
suggesting possible cooperation between the Oct4 group
and the Myc group via Klfs on gene repression in ES
cells–Oct4/STAT3 may introduce Klfs that cooperate
with the members of the Myc group.
In tune with Rbpj’s reasoned role as an activator from
the feature M01111_RBPJK_Q4 discovered in the Oct4-
moderate cluster, the intracellular part of the cell surface
Notch1 receptor (Notch1-IC) alters the function of
Rbpj to be a transcription activator [28]. Additionally,
Robert-Moreno et al. [29] showed that activation of
Gata2 expression by Notch1/Rbpj is essential for the
onset of definitive hematopoiesis in the mouse embryo.
Our analysis suggested that Zic3 may be a transcriptional
regulator at ES stage. Lim et al. [30] established that
repression of Zic3 in ES cells induces expression of sev-
eral markers of the endodermal lineage and leads to sig-
nificant reduction of Nanog expression, and thus Zic3
plays an important role in the maintenance of pluripo-
tency by preventing endodermal lineage specification in
ES cells. Zic3 may activate repressors of the endoderm
markers and thus works as an activator in ES cells. Given
the above evidence from the existing literatures, other
identified cofactors may also play some unknown roles at
ES/DF stages, and thus may be worth follow-up experi-
mental verification.
Support by target prediction
Based on the formulation of an NB classifier, we pre-
dicted target genes that are regulated by TFs involved in
a feature. The prediction is through checking the change
in the probability ratio for classification after a feature is
excluded from predictors of a classifier that employs the
selected features (see Methods). To provide evidence for
predicted targets, we checked gene expression profiles of
identified cofactors and their predicted targets in another
data set–the RAi (retinoic-acid-induced) data [9]. Gene
expression was profiled for 6 days when ES cells under-
went retinoic-acid-induced differentiation. We treated
day 0 as ES stage and day 4-6 as DF stage, and computed
fold change of the expression profile of day 0 over the
mean expression of day 4-6 as in [16]. We then checked
whether fold change of an identified cofactor in the RAi
data matches its fold change in our study. Besides exact
match, we allowed uniformly high status in one data set
to match positive/negative fold change in the other
because the status indicates potential functioning of a
cofactor at both stages.
If a match is found, expression change of predicted tar-
gets is checked for validation: According to our analysis,
it is expected that expression of targets of an activator at
ES stage and/or a repressor at DF stage (in terms of a
cofactor’s regulatory role) should decrease after differen-
tiation, and conversely, expression of targets of a repres-
sor at ES stage and/or an activator at DF stage should
increase. The proportion of targets whose observed
expression satisfied the above expectation is high, ranging
from 61% to 92%, as shown by Pc in Table 5, where
selected quantiles of targets’ fold change for each feature
are also presented for reference. Based on this consistent
result, the target-prediction practice further supports the
identified cofactors and their regulatory roles.
Among all the predicted targets, an interesting category
is the ones that themselves are main factors or identified
cofactors, indicating cascade regulatory pathways.
Noticeably, multiple targets in this category are observed
for each of the three combinations selected in the uni-
formly-high cluster (Table 4): Otx2, Klf2, Tcfcp2l1,
Pou5f1, and Trp53 are potential targets of E2f1 and
Mef2a; Otx2, Pou5f1, Trp53, and Sox2 are possibly regu-
lated by Sox2 and Smad4 or Smad2; Klf2, Tcfcp2l1,
Pou5f1, Trp53, and Sox2 are among the predicted targets
of Esrrb and Elf1 or Elf2 or Gabpa. Other clusters do not
show this phenomenon. It implies that genes in the uni-
formly-high cluster (that is, genes highly associated with
all the 12 main factors) may play important roles in
forming complex network structure and should receive
particular attention when modeling regulatory networks
is the goal of a study. Consistently, the three related top
GO terms enriched in the targets of this cluster are:
Negative regulation of biological process, regulation of
developmental process, and regulation of cell
differentiation.
We summarize biological implications of our results as
follows: Based on the definitions of ES-up/-down fea-
tures, we inferred the regulatory roles of the potential
cofactors involved in the reported features (Table 4),
some of which are supported by relevant literatures; the
gene-classification practice shows that the identified TF
combinations may explain the gene expression; the
expected expression change of the predicted targets in
another data set adds more confidence in the inferred
regulators’ function. The results of this study can provide
new clues to expand the core regulatory network among
main factors and to identify novel combinatorial regula-
tion of the rich expression profiles in mouse ES cells.
Discussion
Although the classification improvement of our
approach for the Oct4 cluster and the Myc cluster com-
paring to the other methods in Table 3 is substantial
and encouraging, the absolute CV errors are quite high.
Such results could be due to the following reasons.
First, as shown in Table 1, there are more significant
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features than what has been enumerated under our
search strategy. Some of them are biologically meaning-
ful in explaining gene expression, and thus have the
potential to further reduce classification errors. For
example, the neuronal repressor REST is involved in the
ES-down feature Oct4.Smad1.M00325_NRSE_B (with P-
value = 2.07 × 10-5) for the Oct4 cluster, which suggests
REST collaborating with the key TFs Oct4 and Smad1
for gene down-regulation at ES stage. In line with its
repressor role, this cofactor has been shown to maintain
self-renewal and pluripotency in mouse ES cells through
suppression of the microRNA miR-21 [31]. Thus, this
ES-down feature may be worth further investigation.
However, one challenging question is how features like
this can be discovered; simply increasing the number of
top features in NB classifiers may include many noisy
features and thus degrade classification performance
according to our experience. Therefore, procedures with
stronger selective power are needed. Second, sophisti-
cated learning methods such as boosting and Bayesian
additive regression trees (BART) may have better classi-
fication performance (as Zhou and Liu [32] demon-
strated in TF-DNA binding problems), but these
methods may have difficulties in interpretation of their
results. In the framework we employed, not only do the
statistical tests help reduce search space by focusing on
significant features for feature selection in classification,
but they also provide ground for biologically meaningful
interpretations of features as we have discussed in the
section of feature significance. Third, although in this
study we focused on TF regulatory control, TF binding
is only one way of gene regulation. Other mechanisms
such as DNA methylation are also involved in regulating
gene expression. Lack of their information may lead to
Table 5 Summary of expression fold change of predicted targets in the RAi data
Cluster Feature Cofactor FC_RAi Nb Ne Pc 1Q Median 3Q
UH E2f1.M00233_MEF2_04 Mef2a N 198 191 0.90 1.67 2.28 4.64
UH Sox2.M00974_SMAD_Q6_01 Smad2 H 92 90 0.89 1.82 3.01 8.50
UH Sox2.M00974_SMAD_Q6_01 Smad4 H 92 90 0.89 1.82 3.01 8.50
UH Esrrb.M00971_ETS_Q6 Elf2 H 150 144 0.92 1.62 2.32 4.12
UH Esrrb.M00971_ETS_Q6 Gabpa H 150 144 0.92 1.62 2.32 4.12
Oct4 Smad1.STAT3.M00052_NFKB Rela H 39 29 0.72 0.99 1.97 2.65
Oct4 Smad1.STAT3.M00415_ AREB6_04 Zeb1 N 36 25 0.76 1.16 1.83 2.65
Oct4 Tcfcp2l1.M00771_ETS_Q4 Elf2 H 90 82 0.82 1.16 1.97 4.15
Oct4 STAT3.M00251_XBP1_01 Xbp1 H 23 23 0.78 1.16 1.75 3.86
Oct4 Nanog.M00462_GATA6_01 Gata6 N 51 48 0.83 1.29 2.10 4.20
Oct4 Esrrb.N00007_SoxOctComp Sox2 & Oct4 P 108 101 0.82 1.14 1.95 4.04
Oct4 Oct4.M00801_CREB_Q3 Atf1 P 45 40 0.75 1.00 1.91 4.41
Myc M00233_MEF2_04 Mef2a N 170 163 0.90 1.33 1.66 2.53
Myc M00971_ETS_Q6 Gabpa H 173 167 0.89 1.33 1.70 2.67
Myc M00971_ETS_Q6 Elf2 H 173 167 0.89 1.33 1.70 2.67
Myc N00003_Otx2 Otx2 P 166 160 0.90 1.34 1.67 2.59
Myc M00034_P53_01 Trp53 P 166 160 0.91 1.34 1.67 2.71
Myc M00512_PPARG_01 Pparg N 167 160 0.89 1.34 1.70 2.59
Myc N00009_Klf4 Klf2 P 184 177 0.89 1.33 1.68 2.58
Myc N00009_Klf4 Klf5 P 184 177 0.89 1.33 1.68 2.58
Myc M00422_FOX J2_01 Foxj2 N 168 161 0.90 1.34 1.70 2.58
Myc M00724_HNF3ALPHA_Q6 Foxa1 N 177 170 0.89 1.32 1.67 2.46
Myc M01011_HNF1_Q6_01 Hnf1b N 180 174 0.89 1.34 1.67 2.48
Myc Myc.M00480_LUN101 Topors H 73 69 0.81 1.15 1.60 2.26
Myc Mycn.M00931_SP1Q6_01 Sp1 H 80 78 0.73 0.95 1.43 2.16
Myc Mycn.N00017_hB_Sall4 Sall4 P 87 82 0.74 0.98 1.57 2.60
Oct4-M M01111_RBPJK_Q4 Rbpj P 62 57 0.61 0.70 1.27 2.23
Oct4-M M00450_ZIC3_01 Zic3 P 43 41 0.63 0.80 1.28 2.23
Oct4-M N00001_Sox2 Sox2 P 49 46 0.57 0.70 1.09 1.45
Oct4-M M00225_STAT3_01 Stat3 H 44 43 0.67 0.84 1.28 1.79
Note: FC_RAi is fold change of cofactor expression. Nb is the number of predicted targets for a feature. Ne is the number of targets having expression available in
[9]. Pc is the proportion of Ne genes with expected expression change. 1Q, Median, and 3Q are, respectively, the 1st quartile, the median, and the 3rd quartile of
targets’ fold change, which is inverted for ES-down features for convenient comparison.
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low classification accuracy. Thus, readers should treat
our report in this study as intermediate results–further
investigation of this challenging classification problem is
needed.
In the current framework, we consider features involving
only one cofactor and up to two main factors. Further
extension to more cofactors and main factors is possible,
and the extension may gain additional capacity to differ-
entiate the gene expression patterns. However, with more
and more specific TF combinations, the support (that is,
genes that are regulated by the involved TFs) may become
less and less, and thus the gained capacity may not be
detected. On the other hand, the extension will lead to
combinatorial explosion. For example, including one more
cofactor will bring ~100 times more features into consid-
eration. This will result in much more tests for each feature
type, which may cause high FDR for the current data size.
In addition, following the logic of combinatorial regulatory
codes, another kind of features would be a pair of main fac-
tors without considering a cofactor in our framework.
Alternatively, one could treat one main factor as a cofactor
of the other main factor. We explored this possibility and
found that little improvement can be made in gene classifi-
cation. This may be because classification happens within
each gene cluster and collaborative efforts among main fac-
tors have already been captured by clustering.
Besides ES genes, other genes with less substantial fold
change, referred to as ES-neutral genes, may also be infor-
mative. If the function of a TF combination is only to acti-
vate genes in ES cells, we expect that the contrast in the
feature between ES-up and ES-down genes may be more
significant than the contrast between ES-up genes and ES-
neutral genes. The reason is that the TF combination may
have a lower chance to randomly occupy regulatory ele-
ments of an ES-down gene (and thus would up-regulate it
at ES stage) than an ES-neutral gene, which may be acti-
vated but has insignificant fold change. Similarly, focusing
on ES genes may be helpful for detecting a TF combina-
tion as a pure ES repressor. On the other hand, if a parti-
cular combination works as either an activator or a
repressor in ES cells depending on other cellular context
or targets, a feature may then be strongly associated with
both ES-up and ES-down genes, leading to insignificant
test results and defeating detection. In this case, the ES-
neutral gene set, containing genes that are not regulated
by the combination, may provide a better contrast for
detecting such a combination. The detection may be con-
ducted in the same framework with one of ES gene sets
replaced by ES-neutral genes. In summary, many possible
directions can be explored based on this study.
Conclusions
This study suggests a list of TF combinations which may
play important regulatory roles in ES cells based on
computational analyses. They serve as top candidates for
experimental evaluation. We provided computational
evidence of the finding from three aspects: 1. The fea-
tures involving identified TF combinations show strong
statistical significance; 2. the classifiers based on them
have the optimal performance in classifying gene expres-
sion and also achieve substantial improvement over clas-
sifiers utilizing only main factor information; 3. their
predicted target genes (based on classification) in
another independent data set show expected fold change
as in our prediction. In addition to the above evidence,
existing literatures provide support for reasoned regula-
tory roles of some identified cofactors. In summary, this
study effectively reveals combinatorial co-binding pat-




Suppose that n binding sites (peaks) of a main factor are
located within 106 base pairs (bps) of a gene’s TSS. The








where fi denotes the ChIP-seq signal intensity on the
ith main factor binding site, di represents the distance
from the site to the gene’s TSS, and d0 is a weighting
constant, controlling the speed of the exponential decay.
Motif selection
If a TF’s expression has small fold change or is very low,
the TF may not function at either ES or DF stage.
Therefore, for motif scanning, we selected motifs whose
corresponding TF’s expression is either uniformly high
or shows positive/negative fold change. Please refer to
Additional file 3 for the list of the selected motifs and
their expression fold change.
Neighborhood construction
With the following procedures, we constructed genomic
regions where we searched for combinatorial TF binding
sites for gene regulation. First, a genomic neighborhood
of a peak (from the ChIP-seq data) is created via
extending 500 base pairs (bps) from the peak center
coordinate in both directions; then, two neighborhoods
are merged into one neighborhood if a peak center in
one neighborhood is located within 500 bps of a peak
center in the other neighborhood; the merging operation
is made recursively till no two neighborhoods can be
merged. We focused on neighborhoods which include at
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least two peaks. The above construction and considera-
tion were inspired by [11] and [12]–they had discovered
a good number of genomic locations co-occupied by
multiple TFs based on ChIP-seq and bioChIP-chip
experiments, respectively. The neighboring peaks indi-
cate that these genomic islands may be potential regula-
tory regions where co-binding is likely to happen.
Binding-site scanning procedure
We now describe how we computed motif score of a
sequence segment of width w–a w-mer–and determined
whether it is a binding site. Given a sequence S of
length L, we first estimated ψb, the transition matrix of
a first-order Markov model as a background model.
Given the position-specific weight matrix (PWM) for a
motif ψm, we then calculated the following probability
ratio r as the motif score for a w-mer located at the ith
position of S for i = 1,..., L - w + 1:
r =
P(S[i, i + w− 1]|m)
P(S[i, i + w− 1]|b) . (2)
We also scanned the complementary strand of S for
computing motif scores. Note that motif scanning was
applied after repeat sequences were masked out.
To decide whether a motif score is significant, we ran-
domly drew 20 matched control sequences from the
mm8 genome using the CisGenome program [33] for a
neighborhood sequence. For every control sequence, its
length and distance from its center to its closest gene’s
TSS matched the length of the neighborhood sequence
and the distance from the neighborhood center to the
TSS of the gene closest to the neighborhood, respec-
tively. The later match is shown to provide a compara-
tive or better match to binding region GC-content than
genome-wide controls [34]. Thus, it improves accuracy
of binding site detection. We first scanned matched
control sequences for a cluster with Oct4 PWM and
built a null distribution for the motif scores of Oct4.
We then found a cutoff P-value 9.09 × 10-5 correspond-
ing to r = 1000, which is reasonable according to our
past experience. We then collected significant sites as
Oct4 binding sites where corresponding w-mers’ scores
are greater than 1000. For other motifs, we first used
P-value 9.09 × 10-5 to find score cutoffs from null distri-
butions and then recorded binding sites according to the
cutoffs.
Computing feature scores
Let k index the associated neighborhoods of a gene.
Suppose that nk and mk are the number of main factor
binding sites (peaks) and the number of binding sites of
a cofactor in the kth neighborhood, respectively. The
























where fki denotes the ChIP-seq signal intensity on the
ith main factor binding site, gkj denotes the motif score
of the jth cofactor binding site, and dki and dkj represent
the distances to the gene’s TSS from the two sites,
respectively. Similar to the distance limit for allowing a
binding site to be associated with a gene in [14], the
longest distance for associating a neighborhood with a
gene, d, is taken to be 106–that is, neighborhoods that
are 1 million bps away from the TSS are not considered,
and d0 = 5000 is a constant for controlling the exponen-
tial decay. Feature scores are computed and used in nat-
ural-log scale.
We can understand a summation term, which corre-
sponds to contribution from the kth neighborhood, in
(3) by parts: The part in the brackets is a combined
binding strength based on respective geometric
averages–one component from main factors and the
other from a cofactor; it is then exponentially down-
weighted according to the average distance from binding
sites to the TSS.
The feature score definition is an extension of the
definition of association scores (1). Since an association
score is defined for only one main factor with a gene, it
concerns only the main factor’s ChIP-seq signal intensi-
ties and the distances from their binding sites to the
TSS. The study [14] showed that in predicting gene
expression association scores are superior to traditional
scores based on binary association of binding sites with
a gene, which do not utilize ChIP-seq signal intensities
and relative distances between sites and a gene. In our
study, we extend association scores to feature scores for
quantifying the association between a TF combination
and a gene. To avoid possible confusion about the con-
cepts of association scores and feature scores, Figure 7
summarizes their differences and relationship.
NB classifier and feature enumeration
Suppose there are k predictors in total, denoted by X
with Xj being the jth predictor for j = 1,..., k. Let Y
denote class label: Y = 1 indicates that a gene is an ES-
up gene; Y = 0 indicates that a gene is an ES-down
gene. Let Ψ represent related parameters. An NB classi-
fier is defined by
P(Y = 1|X,)








The classifier compares probabilities that a gene
belongs to a class given its predictors, and assigns a
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class label y = argmax yÎ{1,0} P(Y = y | X, Ψ) to a gene.
In the equation, P(Y) denotes the prior probabilities of
the two classes, and P(Xj | Ψ jY) is the conditional den-
sity of the jth predictor given Y (= 1 or 0). The probabil-
ity of a gene belonging to a class given predictors X is
computed under the assumption that predictors are
conditionally independent of one another given a class
label.
In Equation (4), the prior probabilities of the two
classes P(Y) are p1 and 1- p1 for Y = 1 and 0, respec-
tively. In the density of the jth predictor P(Xj | Ψ jY), Xj
is a random variable denoting (1) whether the feature
score of the jth predictor exists and (2) the feature score
if it exists (note that a feature score may not exist for a
gene if the feature cannot be associated with the gene,
as explained at the end of the section of Feature and
feature scores): Let the indicator variable Ij = 1 if the
feature score of the jth predictor exists for a gene, and Ij
= 0 otherwise; then if Ij = 1, P(Xj | Ψ jY) = ljYfjY(Xj),
where ljY is the probability that a gene with class label
Y has a feature score of the jth predictor, and fjY is the
density function of the jth predictor’s feature score in
class Y. On the other hand, if the feature of the jth pre-
dictor cannot be associated with a gene, Xj is then
reduced to the indicator variable Ij, and thus P(Xj | Ψ jY)
= 1 - ljY given Ij = 0 in this case. To summarize the
above two cases, P(Xj|jY) = (1− λjY)1−Ij(λjY fjY(Xj))Ij .
The parameters and density functions were estimated
from a training data set as follows pˆ1 =
N1
N
, where N1 is
the number of ES-up genes, and N is the total number
of ES genes. λˆjY =
NjY
NY
, where NjY is the number of the
genes having Xj’s scores in class Y, and NY is the num-
ber of the genes in class Y. We adopted a kernel method










where x jyi is the score of Xj for the ith gene in class
Y, K(·) is the standard normal density, and hjY is the
bandwidth of the kernel for Xj in class Y, calculated
according to Silverman’s rule of thumb (see page 48 of
[35]). Since top features or predictors from two-sample
proportion test are based on only binary information,
the density function of feature scores fjY(x) is excluded
from the computation of P(Xj | ΨjY) for these predictors.
Given one type of ES-up features and one type of ES-
down features, we enumerated every possible combina-
tion of k1 and k2 (0 ≤ k1, k2 ≤ 20) for the above NB clas-
sifier formulation. We considered utilizing up to 20 top
features due to the following two reasons: 1. Such an
option covers 2/3 of the significant cases in Table 1,
that is, the number of significant features (of one type)
is less than 20 for 16 out of the 24 cases in the table; 2.
we observed that CV errors in general increase consid-
erably when k1 and/or k2 become large (for example,
Figure 4). Predictors involving main factors alone were
also included (as control variables), with their associa-
tion scores utilized in the same way as feature scores.
When k1 = k2 = 0, these are the only predictors. Mini-
mum CV errors were used to determine the number of
features k1 and k2.
Target prediction
A gene is predicted to be regulated by a TF combination
involved in an ES-up (-down) feature if this gene satis-
fies the following two conditions: 1. It is an ES-up
(-down) gene; 2. after the feature is excluded from pre-
dictors of an NB classifier, we observe a decrease (an
increase) in the ratio of the probability of the gene as an
ES-up gene over that as an ES-down gene with the
Extended to
a gene and a main factor
Association score
Association strength between 
Equivalent
a gene and a TF combination of
w main factors and a cofactor
Feature score
Association strength between 
Equivalent
Figure 7 Concepts of association scores and feature scores and their relationship. The concepts are briefly defined in the bottom two
boxes.
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remaining predictors (at the left-hand side of Equation
(4)). The first condition ensures that target prediction
be consistent with ES-up/-down feature definitions,
which are based on statistical significance of one-sided
test results; the operation in the second condition
intends to mimic knockout of a TF combination and to
check expected expression change of potential targets.
Additional file 14 lists predicted targets ranked by fold
change in the probability ratio. Readers can refer to
Additional file 15 for different Gene Ontology (GO)
terms, which were retrieved by the DAVID program
[36], enriched in the targets of different clusters to learn
about their biological functions.
Additional material
Additional file 1: Association score components. Association score
components (rescaled for display purpose) with genes aligned between
(a) and (b) as in Figure 3. (a) Sum of the ChIP-seq intensities:
∑n
i=1 fi






Additional file 2: ES gene sets. This table lists ES genes in different
clusters.
Additional file 3: Pre-selected motifs. This table lists pre-selected
motifs.
Additional file 4: Number of ChIP-seq binding sites of main factors
of interest in neighborhoods. This table lists the number of ChIP-seq
binding sites of main factors of interest in neighborhoods for each
cluster.
Additional file 5: Summary of neighborhood lengths. This table
summarizes neighborhood lengths (in bps).
Additional file 6: Percentiles of distances from neighborhood
centers to TSS’s. This table summarizes distances (in bps) from
neighborhood centers to TSS’s.
Additional file 7: Feature scores for the uniformly-high cluster (a).
This table contains first 1/3 of feature scores (in log scale) for the
uniformly-high cluster, with NA indicating nonexistence of scores.
Additional files 7, 8 and 9 should be combined (or concatenated into
one file) to get all feature scores for the uniformly-high cluster.
Additional file 8: Feature scores for the uniformly-high cluster (b).
This table contains second 1/3 of feature scores (in log scale) for the
uniformly-high cluster.
Additional file 9: Feature scores for the uniformly-high cluster (c).
This table contains third 1/3 of feature scores (in log scale) for the
uniformly-high cluster.
Additional file 10: Feature scores for the Oct4 cluster. This table
contains feature scores (in log scale) for the Oct4 cluster.
Additional file 11: Feature scores for the Myc cluster. This table
contains feature scores (in log scale) for the Myc cluster.
Additional file 12: Feature scores for the Oct4-moderate cluster. This
table contains feature scores (in log scale) for the Oct4-moderate cluster.
Additional file 13: Significant features. This table lists significant
features.
Additional file 14: Predicted target genes. This table lists predicted
target genes.
Additional file 15: Enriched GO terms for predicted targets. This
table lists enriched GO terms for predicted targets.
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